Gyros Protein Technologies introduces Gyrolab p24 Kit to support the cell and gene therapy market
Ready-to-use kit enables lentivirus titer determinations during the manufacture of lentivirus vectors Uppsala, Sweden, 09 September 2019: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® p24 Kit, for lentivirus titer determination in lentivirus vector manufacturing. The new kit adds to the... Read more